Oct 22, 2025 · Herceptin (chemical name: trastuzumab) is a HER2 inhibitor targeted therapy. Herceptin works against HER2-positive breast cancers by blocking the ability of the cancer …

Apr 17, 2025 · Learn how targeted therapies, including monoclonal antibodies (such as Herceptin or Trastuzumab), can be used to treat breast cancer.

Aug 10, 2021 · Targeted Drug Therapy for Breast Cancer Targeted drug therapy use s medicines that are directed at (target) proteins on breast cancer cells that help them grow, spread, and …

Mar 3, 2025 · Breast cancer treatment For people with HER2-positive early breast cancer, chemotherapy plus trastuzumab cuts the risk of recurrence (a return of breast cancer) in half …

Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.

Targeted therapies—a form of precision medicine—have represented some of the most important breakthroughs in breast cancer research. Today, oncologists have numerous targeted …

May 28, 2024 · Trastuzumab is a targeted therapy known as a monoclonal antibody, a modified version of an immune system protein, that can target proteins on HER2-positive breast cancer …

Learn about Herceptin® (trastuzumab), a targeted therapy approved for the treatment of HER2+ early breast cancer. See full safety & Boxed Warnings for more information.

Jul 24, 2024 · What are HER2-targeted therapies? Traditional chemotherapy, radiation and surgery still play an important role in the treatment of HER2-positive cancers. These …

The 2019 Lasker-DeBakey Clinical Medical Research Award honored Dennis J. Slamon, Axel Ullrich, and H. Michael Shepard for their paradigm-shifting invention of trastuzumab …